Vanguard Capital Management Discloses New 5.05% Stake in Twist Bioscience Corp (TWST)

On April 30, 2026, Vanguard Capital Management LLC filed a Schedule 13G with the SEC, disclosing a new 5.05% ownership stake in Twist Bioscience Corp (TWST). As of the event date on March 31, 2026, Vanguard reported beneficial ownership of 3,101,909 shares of common stock. This position represents a significant increase from a previous 0.0% holding, establishing Vanguard as a major institutional investor in the company. The filing indicates that Vanguard holds sole dispositive power over all 3,101,909 shares, while maintaining sole voting power over 462,865 shares. The shares were acquired in the ordinary course of business, and the filing includes interests from various affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. The reporting person certified that the securities were not acquired for the purpose of influencing or changing the control of the issuer. This passive investment highlights Vanguard's growing exposure to the synthetic biology and genomics sector through Twist Bioscience.